Cellectar Biosciences(CLRB) - 2020 Q1 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CLRB NASDAQ Capital Market Warrant to purchase common stock, expiring April 20, 2021 CLRBZ NASDAQ Capital Market Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer x Smaller reporting company x Emerging growth company ¨ FORM 10-Q [mark one] x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...